Dr. Lilach O Lerman, MD, PhD
Claim this profileMore about Lilach O Lerman, MD, PhD
Clinical Trial Related
5 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Lilach O Lerman, MD, PhD has experience with
- Quantitative Magnetization Transfer
Breakdown of trials Lilach O Lerman, MD, PhD has run
Hypertension
Renal artery stenosis
High Blood Pressure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lilach O Lerman, MD, PhD specialize in?
Lilach O Lerman, MD, PhD focuses on Hypertension and Renal artery stenosis. In particular, much of their work with Hypertension has involved treating patients, or patients who are undergoing treatment.
Is Lilach O Lerman, MD, PhD currently recruiting for clinical trials?
No, Lilach O Lerman, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lilach O Lerman, MD, PhD has studied deeply?
Yes, Lilach O Lerman, MD, PhD has studied treatments such as Quantitative Magnetization Transfer.
What is the best way to schedule an appointment with Lilach O Lerman, MD, PhD?
Apply for one of the trials that Lilach O Lerman, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.